<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34830069</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>22</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">12175</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms222212175</ELocationID><Abstract><AbstractText>There is ample evidence that nucleocytoplasmic-transport deficits could play an important role in the pathology of amyotrophic lateral sclerosis (ALS). However, the currently available data are often circumstantial and do not fully clarify the exact causal and temporal role of nucleocytoplasmic transport deficits in ALS patients. Gaining this knowledge will be of great significance in order to be able to target therapeutically nucleocytoplasmic transport and/or the proteins involved in this process. The availability of good model systems to study the nucleocytoplasmic transport process in detail will be especially crucial in investigating the effect of different mutations, as well as of other forms of stress. In this review, we discuss the evidence for the involvement of nucleocytoplasmic transport defects in ALS and the methods used to obtain these data. In addition, we provide an overview of the therapeutic strategies which could potentially counteract these defects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vanneste</LastName><ForeName>Joni</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Experimental Neurology, Department of Neurosciences and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, B-3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Center for Brain &amp; Disease Research, VIB, B-3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0104-4067</Identifier><AffiliationInfo><Affiliation>Experimental Neurology, Department of Neurosciences and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, B-3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Center for Brain &amp; Disease Research, VIB, B-3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029543">Nucleocytoplasmic Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020931">ran GTP-Binding Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="Y">Active Transport, Cell Nucleus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022022" MajorTopicYN="N">Nuclear Pore</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029543" MajorTopicYN="N">Nucleocytoplasmic Transport Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020931" MajorTopicYN="N">ran GTP-Binding Protein</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34830069</ArticleId><ArticleId IdType="pmc">PMC8620263</ArticleId><ArticleId IdType="doi">10.3390/ijms222212175</ArticleId><ArticleId IdType="pii">ijms222212175</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cooper G.M. The Cell: A Molecular Approach. 2nd ed. Sinauer Associates; Sunderland, MA, USA: 2000.</Citation></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D., Mansfield C., Moussy A., Hermine O. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front. Aging Neurosci. 2017;9:68. doi: 10.3389/fnagi.2017.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada H. Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Expert Opin. Pharm. 2017;18:735&#x2013;738. doi: 10.1080/14656566.2017.1319937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2017.1319937</ArticleId><ArticleId IdType="pubmed">28406335</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>McCord J.M., Fridovich I. Superoxide dismutase an enzymic function for erythrocuprein (hemocuprein) J. Biol. Chem. 1969;244:6049&#x2013;6055. doi: 10.1016/S0021-9258(18)63504-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)63504-5</ArticleId><ArticleId IdType="pubmed">5389100</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr. Neurol. Neurosci. Rep. 2006;6:37&#x2013;46. doi: 10.1007/s11910-996-0008-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-996-0008-9</ArticleId><ArticleId IdType="pubmed">16469270</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H., Dormann D. TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett. 2017;591:1489&#x2013;1507. doi: 10.1002/1873-3468.12646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12646</ArticleId><ArticleId IdType="pubmed">28380257</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 2016;138:95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziortzouda P., Van Den Bosch L., Hirth F. Triad of TDP43 control in neurodegeneration: Autoregulation, localization and aggregation. Nat. Rev. Neurosci. 2021;22:197&#x2013;208. doi: 10.1038/s41583-021-00431-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-021-00431-1</ArticleId><ArticleId IdType="pubmed">33654312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinszner H., Sok J., Immanuel D., Yin Y., Ron D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell Sci. 1997;110:1741&#x2013;1750. doi: 10.1242/jcs.110.15.1741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.110.15.1741</ArticleId><ArticleId IdType="pubmed">9264461</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Ghasemi M., Brown R.H. Emerging mechanisms of molecular pathology in ALS. J. Clin. Investig. 2015;125:2548. doi: 10.1172/JCI82693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI82693</ArticleId><ArticleId IdType="pmc">PMC4518693</ArticleId><ArticleId IdType="pubmed">26030230</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E., Boeynaems S., Kato M., Guo L., Caulfield T.R., Steyaert J., Scheveneels W., Wilmans N., Haeck W., Hersmus N., et al. Molecular dissection of FUS points at synergistic effect of low-complexity domains in toxicity. Cell Rep. 2018;24:529&#x2013;537. doi: 10.1016/j.celrep.2018.06.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.06.070</ArticleId><ArticleId IdType="pmc">PMC6077250</ArticleId><ArticleId IdType="pubmed">30021151</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I., Van Langenhove T., van der Zee J., Sleegers K., Philtjens S., Kleinberger G., Janssens J., Bettens K., Van Cauwenberghe C., Pereson S., et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study. Lancet Neurol. 2012;11:54&#x2013;65. doi: 10.1016/S1474-4422(11)70261-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70261-7</ArticleId><ArticleId IdType="pubmed">22154785</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.-Y., Zhou Z.-R., Che C.-H., Liu C.-Y., He R.-L., Huang H.-P. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Zee J., Gijselinck I., Dillen L., Van Langenhove T., Theuns J., Engelborghs S., Philtjens S., Vandenbulcke M., Sleegers K., Sieben A., et al. A pan-European study of the C9orf72 repeat associated with FTLD: Geographic prevalence, genomic instability, and intermediate repeats. Hum. Mutat. 2013;34:363&#x2013;373. doi: 10.1002/humu.22244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22244</ArticleId><ArticleId IdType="pmc">PMC3638346</ArticleId><ArticleId IdType="pubmed">23111906</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E., Renton A.E., Mok K., Dopper E.G.P., Waite A., Rollinson S., Chi&#xf2; A., Restagno G., Nicolaou N., Simon-Sanchez J., et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study. Lancet. Neurol. 2012;11:323&#x2013;330. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine T.P., Daniels R.D., Gatta A.T., Wong L.H., Hayes M.J. The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics. 2013;29:499&#x2013;503. doi: 10.1093/bioinformatics/bts725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts725</ArticleId><ArticleId IdType="pmc">PMC3570213</ArticleId><ArticleId IdType="pubmed">23329412</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Iyer L.M., He F., Aravind L. Discovery of Novel DENN proteins: Implications for the evolution of eukaryotic intracellular membrane structures and human disease. Front. Genet. 2012;3:283. doi: 10.3389/fgene.2012.00283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2012.00283</ArticleId><ArticleId IdType="pmc">PMC3521125</ArticleId><ArticleId IdType="pubmed">23248642</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S., Subramanian V., Acharya K.R. C9orf72, a protein associated with amyotrophic lateral sclerosis (ALS) is a guanine nucleotide exchange factor. PeerJ. 2018;6:e5815. doi: 10.7717/peerj.5815.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.5815</ArticleId><ArticleId IdType="pmc">PMC6195791</ArticleId><ArticleId IdType="pubmed">30356970</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M.A., Sundaramoorthy V., Sultana J.M., Yang S., Atkinson R.A.K., Levina V., Halloran M.A., Gleeson P.A., Blair I.P., Soo K.Y., et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet. 2014;23:3579&#x2013;3595. doi: 10.1093/hmg/ddu068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu068</ArticleId><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C.P., Smith E.F., Bauer C.S., Moller A., Hautbergue G.M., Ferraiuolo L., Myszczynska M.A., Higginbottom A., Walsh M.J., Whitworth A.J., et al. The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO J. 2016;35:1656&#x2013;1676. doi: 10.15252/embj.201694401.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694401</ArticleId><ArticleId IdType="pmc">PMC4969571</ArticleId><ArticleId IdType="pubmed">27334615</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C., Campanari M.-L., Julie Corbier C., Gaucherot A., Kolb-Cheynel I., Oulad-Abdelghani M., Ruffenach F., Page A., Ciura S., Kabashi E., et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 2016;35:1276&#x2013;1297. doi: 10.15252/embj.201593350.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S., MacNair L., McGoldrick P., McKeever P.M., McLean J.R., Zhang M., Keith J., Zinman L., Rogaeva E., Robertson J. Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis. Ann. Neurol. 2015;78:568&#x2013;583. doi: 10.1002/ana.24469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24469</ArticleId><ArticleId IdType="pubmed">26174152</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick P., Sellier C., Mackenzie I.R.A., Cheng C.-Y., Tahraoui-Bories J., Martinat C., Pasterkamp R.J., Prudlo J., Edbauer D., Oulad-Abdelghani M., et al. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol. Commun. 2018;6:72. doi: 10.1186/s40478-018-0579-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0579-0</ArticleId><ArticleId IdType="pmc">PMC6091050</ArticleId><ArticleId IdType="pubmed">30075745</ArticleId></ArticleIdList></Reference><Reference><Citation>Braems E., Swinnen B., Van Den Bosch L. C9orf72 loss-of-function: A trivial, stand-alone or additive mechanism in C9 ALS/FTD? Acta Neuropathol. 2020;140:625&#x2013;643. doi: 10.1007/s00401-020-02214-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02214-x</ArticleId><ArticleId IdType="pmc">PMC7547039</ArticleId><ArticleId IdType="pubmed">32876811</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W., Van Den Bosch L. RNA toxicity in non-coding repeat expansion disorders. EMBO J. 2020;39:e101112. doi: 10.15252/embj.2018101112.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018101112</ArticleId><ArticleId IdType="pmc">PMC6939197</ArticleId><ArticleId IdType="pubmed">31721251</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Walsh M.J., Higginbottom A., Robin Highley J., Dickman M.J., Edbauer D., Ince P.G., Wharton S.B., Wilson S.A., Kirby J., et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain. 2014;137:2040&#x2013;2051. doi: 10.1093/brain/awu120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S., Serrano A., Gerbino V., Giorgi A., Di Francesco L., Nencini M., Bozzo F., Schinin&#xe0; M.E., Bagni C., Cestra G., et al. Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS. J. Cell Sci. 2015;128:1787. doi: 10.1242/jcs.165332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.165332</ArticleId><ArticleId IdType="pubmed">25788698</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler A.R., Donnelly C.J., Periz G., Simko E.A.J., Shaw P.G., Kim M.-S., Maragakis N.J., Troncoso J.C., Pandey A., Sattler R., et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195&#x2013;200. doi: 10.1038/nature13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Taylor J.P. The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front. Mol. Neurosci. 2017;10:35. doi: 10.3389/fnmol.2017.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gr&#xf6;nke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., Moens T., Norona F.E., Woollacott I.O.C., Pietrzyk J., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Lu Y., Lopez-Gonzalez R., Kim N.C., Almeida S., Lee K.-H., Badders N., Valentine M., Miller B.L., Wong P.C., et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Tan W., Westergard T., Krishnamurthy K., Markandaiah S.S., Shi Y., Lin S., Shneider N.A., Monaghan J., Pandey U.B., et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84:1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Michiels E., Gijselinck I., Sieben A., Jovi&#x10d;i&#x107; A., De Baets G., Scheveneels W., Steyaert J., Cuijt I., et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci. Rep. 2016;6:20877. doi: 10.1038/srep20877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20877</ArticleId><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H., Hornburg D., Czuppa M., Bader J., Michaelsen M., Farny D., Arzberger T., Mann M., Meissner F., Edbauer D. Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity. Life Sci. Alliance. 2018;1:e201800070. doi: 10.26508/lsa.201800070.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201800070</ArticleId><ArticleId IdType="pmc">PMC6238541</ArticleId><ArticleId IdType="pubmed">30456350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Yagi T., Cammack A.J., Mahadevan J., Kuroda M., Harms M.B., Miller T.M., Urano F. Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. Hum. Mol. Genet. 2016;25:1803&#x2013;1813. doi: 10.1093/hmg/ddw052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw052</ArticleId><ArticleId IdType="pmc">PMC4986334</ArticleId><ArticleId IdType="pubmed">26931465</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Mori E., Kato M., Xiang S., Wu L., Kwon I., McKnight S.L. Toxic PR poly-dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers. Cell. 2016;167:789&#x2013;802. doi: 10.1016/j.cell.2016.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.003</ArticleId><ArticleId IdType="pmc">PMC5076566</ArticleId><ArticleId IdType="pubmed">27768897</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.-H., Zhang P., Kim H.J., Mitrea D.M., Sarkar M., Freibaum B.D., Cika J., Coughlin M., Messing J., Molliex A., et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167:774&#x2013;788. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Gendron T.F., Karydas A., Tran H., Yang D., Petrucelli L., Miller B.L., Almeida S., Gao F.-B. Poly(GR) in C9ORF72-Related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Kovacs D., Konijnenberg A., Timmerman E., Volkov A., Guharoy M., De Decker M., Jaspers T., Ryan V.H., et al. Phase Separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol. Cell. 2017;65:1044&#x2013;1055. doi: 10.1016/j.molcel.2017.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.02.013</ArticleId><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli L., Young F.L., Boeynaems S., De Decker M., Mehta A.R., Swijsen A., Fazal R., Guo W., Moisse M., Beckers J., et al. C9orf72-derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility. Sci. Adv. 2021;7:eabg3013. doi: 10.1126/sciadv.abg3013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg3013</ArticleId><ArticleId IdType="pmc">PMC8034861</ArticleId><ArticleId IdType="pubmed">33837088</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi K.Y., Mori E., Nizami Z.F., Lin Y., Kato M., Xiang S., Wu L.C., Ding M., Yu Y., Gall J.G., et al. Toxic PR(n) poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proc. Natl. Acad. Sci. USA. 2017;114:E1111&#x2013;E1117. doi: 10.1073/pnas.1620293114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1620293114</ArticleId><ArticleId IdType="pmc">PMC5320981</ArticleId><ArticleId IdType="pubmed">28069952</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutten S., Usluer S., Bourgeois B., Simonetti F., Odeh H.M., Fare C.M., Czuppa M., Hruska-Plochan M., Hofweber M., Polymenidou M., et al. Nuclear import receptors directly bind to arginine-rich dipeptide repeat proteins and suppress their pathological interactions. Cell Rep. 2020;33:108538. doi: 10.1016/j.celrep.2020.108538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108538</ArticleId><ArticleId IdType="pmc">PMC7814465</ArticleId><ArticleId IdType="pubmed">33357437</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes L.R., Duan L., Bowen K., Kalab P., Rothstein J.D. C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. eLife. 2020;9:e51685. doi: 10.7554/eLife.51685.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.51685</ArticleId><ArticleId IdType="pmc">PMC7051184</ArticleId><ArticleId IdType="pubmed">32119645</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateishi T., Hokonohara T., Yamasaki R., Miura S., Kikuchi H., Iwaki A., Tashiro H., Furuya H., Nagara Y., Ohyagi Y., et al. Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation. Acta Neuropathol. 2010;119:355&#x2013;364. doi: 10.1007/s00401-009-0621-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0621-1</ArticleId><ArticleId IdType="pubmed">19967541</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R.A., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H., et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 2007;61:427&#x2013;434. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanznaster D., Hergesheimer R., Vourc&#x2019;h P., Corcia P., Blasco H. TDP43 aggregates: The &#x2018;Schrodinger&#x2019;s cat&#x2019; in amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2021;22:514. doi: 10.1038/s41583-021-00477-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-021-00477-1</ArticleId><ArticleId IdType="pubmed">34103710</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziortzouda P., Van Den Bosch L., Hirth F. Reply to &#x2018;TDP43 aggregates: The &#x2018;Schrodinger&#x2019;s cat&#x2019; in amyotrophic lateral sclerosis&#x2019;. Nat. Rev. Neurosci. 2021;22:515. doi: 10.1038/s41583-021-00478-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-021-00478-0</ArticleId><ArticleId IdType="pubmed">34103711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M.E., Mackenzie I.R.A., Capell A., Schmid B., et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010;29:2841&#x2013;2857. doi: 10.1038/emboj.2010.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.143</ArticleId><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z.C., Chook Y.M. Structural and energetic basis of ALS-causing mutations in the atypical proline-tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS) Proc. Natl. Acad. Sci. USA. 2012;109:12017&#x2013;12021. doi: 10.1073/pnas.1207247109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1207247109</ArticleId><ArticleId IdType="pmc">PMC3409756</ArticleId><ArticleId IdType="pubmed">22778397</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent L., Vizard T.N., Smith B.N., Topp S.D., Vance C., Gkazi A., Miller J., Shaw C.E., Talbot K. Autosomal dominant inheritance of rapidly progressive amyotrophic lateral sclerosis due to a truncation mutation in the fused in sarcoma (FUS) gene. Amyotroph. Lateral Scler. Front. Degener. 2014;15:557&#x2013;562. doi: 10.3109/21678421.2014.920033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.920033</ArticleId><ArticleId IdType="pubmed">24899262</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angelo M.A., Hetzer M.W. Structure, dynamics and function of nuclear pore complexes. Trends Cell Biol. 2008;18:456&#x2013;466. doi: 10.1016/j.tcb.2008.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2008.07.009</ArticleId><ArticleId IdType="pmc">PMC2697926</ArticleId><ArticleId IdType="pubmed">18786826</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin D.H., Hoelz A. The structure of the nuclear pore complex (An update) Annu. Rev. Biochem. 2019;88:725&#x2013;783. doi: 10.1146/annurev-biochem-062917-011901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-062917-011901</ArticleId><ArticleId IdType="pmc">PMC6588426</ArticleId><ArticleId IdType="pubmed">30883195</ArticleId></ArticleIdList></Reference><Reference><Citation>Strambio-De-Castillia C., Niepel M., Rout M.P. The nuclear pore complex: Bridging nuclear transport and gene regulation. Nat. Rev. Mol. Cell Biol. 2010;11:490&#x2013;501. doi: 10.1038/nrm2928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2928</ArticleId><ArticleId IdType="pubmed">20571586</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xfc;hlen R., Fahrenkrog B. Moonlighting nuclear pore proteins: Tissue-specific nucleoporin function in health and disease. Histochem. Cell Biol. 2018;150:593&#x2013;605. doi: 10.1007/s00418-018-1748-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-018-1748-8</ArticleId><ArticleId IdType="pubmed">30361777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Taylor J.P. Lost in transportation: Nucleocytoplasmic transport defects in ALS and other neurodegenerative diseases. Neuron. 2017;96:285&#x2013;297. doi: 10.1016/j.neuron.2017.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.029</ArticleId><ArticleId IdType="pmc">PMC5678982</ArticleId><ArticleId IdType="pubmed">29024655</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H.B., G&#xf6;rlich D. Transport selectivity of nuclear pores, phase separation, and membraneless organelles. Trends Biochem. Sci. 2016;41:46&#x2013;61. doi: 10.1016/j.tibs.2015.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2015.11.001</ArticleId><ArticleId IdType="pubmed">26705895</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook A., Bono F., Jinek M., Conti E. Structural biology of nucleocytoplasmic transport. Annu. Rev. Biochem. 2007;76:647&#x2013;671. doi: 10.1146/annurev.biochem.76.052705.161529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.76.052705.161529</ArticleId><ArticleId IdType="pubmed">17506639</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Gelles J., Musser S.M. Imaging of single-molecule translocation through nuclear pore complexes. Proc. Natl. Acad. Sci. USA. 2004;101:12887&#x2013;12892. doi: 10.1073/pnas.0403675101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0403675101</ArticleId><ArticleId IdType="pmc">PMC516490</ArticleId><ArticleId IdType="pubmed">15306682</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribbeck K., G&#xf6;rlich D. Kinetic analysis of translocation through nuclear pore complexes. EMBO J. 2001;20:1320&#x2013;1330. doi: 10.1093/emboj/20.6.1320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.6.1320</ArticleId><ArticleId IdType="pmc">PMC145537</ArticleId><ArticleId IdType="pubmed">11250898</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossareh-Nazari B., Gwizdek C., Dargemont C. Protein export from the nucleus. Traffic. 2001;2:684&#x2013;689. doi: 10.1034/j.1600-0854.2001.21002.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0854.2001.21002.x</ArticleId><ArticleId IdType="pubmed">11576444</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#x131;rl&#x131; K., Karaca S., Dehne H.J., Samwer M., Pan K.T., Lenz C., Urlaub H., G&#xf6;rlich D. A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. eLife. 2015;4:e11466. doi: 10.7554/eLife.11466.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.11466</ArticleId><ArticleId IdType="pmc">PMC4764573</ArticleId><ArticleId IdType="pubmed">26673895</ArticleId></ArticleIdList></Reference><Reference><Citation>Harel A., Forbes D.J. Importin beta: Conducting a much larger cellular symphony. Mol. Cell. 2004;16:319&#x2013;330. doi: 10.1016/j.molcel.2004.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2004.10.026</ArticleId><ArticleId IdType="pubmed">15525506</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;rlich D., Kutay U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 1999;15:607&#x2013;660. doi: 10.1146/annurev.cellbio.15.1.607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.cellbio.15.1.607</ArticleId><ArticleId IdType="pubmed">10611974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange A., Mills R.E., Lange C.J., Stewart M., Devine S.E., Corbett A.H. Classical nuclear localization signals: Definition, function, and interaction with importin alpha. J. Biol. Chem. 2007;282:5101&#x2013;5105. doi: 10.1074/jbc.R600026200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R600026200</ArticleId><ArticleId IdType="pmc">PMC4502416</ArticleId><ArticleId IdType="pubmed">17170104</ArticleId></ArticleIdList></Reference><Reference><Citation>Twyffels L., Gueydan C., Kruys V. Transportin-1 and Transportin-2: Protein nuclear import and beyond. FEBS Lett. 2014;588:1857&#x2013;1868. doi: 10.1016/j.febslet.2014.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.04.023</ArticleId><ArticleId IdType="pubmed">24780099</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.J., Cansizoglu A.E., S&#xfc;el K.E., Louis T.H., Zhang Z., Chook Y.M. Rules for nuclear localization sequence recognition by karyopherin beta 2. Cell. 2006;126:543&#x2013;558. doi: 10.1016/j.cell.2006.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.05.049</ArticleId><ArticleId IdType="pmc">PMC3442361</ArticleId><ArticleId IdType="pubmed">16901787</ArticleId></ArticleIdList></Reference><Reference><Citation>Cansizoglu A.E., Lee B.J., Zhang Z.C., Fontoura B.M.A., Chook Y.M. Structure-based design of a pathway-specific nuclear import inhibitor. Nat. Struct. Mol. Biol. 2007;14:452&#x2013;454. doi: 10.1038/nsmb1229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1229</ArticleId><ArticleId IdType="pmc">PMC3437620</ArticleId><ArticleId IdType="pubmed">17435768</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;kel S., Mingot J.-M., Schwarzmaier P., Hartmann E., G&#xf6;rlich D. Importins fulfil a dual function as nuclear import receptors and cytoplasmic chaperones for exposed basic domains. EMBO J. 2002;21:377&#x2013;386. doi: 10.1093/emboj/21.3.377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/21.3.377</ArticleId><ArticleId IdType="pmc">PMC125346</ArticleId><ArticleId IdType="pubmed">11823430</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Kim H.J., Wang H., Monaghan J., Freyermuth F., Sung J.C., O&#x2019;Donovan K., Fare C.M., Diaz Z., Singh N., et al. Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell. 2018;173:677&#x2013;692. doi: 10.1016/j.cell.2018.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M., Hutten S., Bourgeois B., Spreitzer E., Niedner-Boblenz A., Schifferer M., Ruepp M.-D., Simons M., Niessing D., Madl T., et al. Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell. 2018;173:706&#x2013;719. doi: 10.1016/j.cell.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.004</ArticleId><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S., Wang G., Randle S.J., Ruggeri F.S., Varela J.A., Lin J.Q., Phillips E.C., Miyashita A., Williams D., Str&#xf6;hl F., et al. FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-&#x3c0; interactions. Cell. 2018;173:720&#x2013;734. doi: 10.1016/j.cell.2018.03.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.056</ArticleId><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa T., Ali R., Jiou J., Fung H.Y.J., Burke K.A., Kim S.J., Lin Y., Peeples W.B., Saltzberg D., Soniat M., et al. Nuclear Import receptor inhibits phase separation of FUS through binding to multiple sites. Cell. 2018;173:693&#x2013;705. doi: 10.1016/j.cell.2018.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.003</ArticleId><ArticleId IdType="pmc">PMC6234985</ArticleId><ArticleId IdType="pubmed">29677513</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasso M. The ran GTPase: Theme and variations. Curr. Biol. 2002;12:R502&#x2013;R508. doi: 10.1016/S0960-9822(02)00970-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(02)00970-3</ArticleId><ArticleId IdType="pubmed">12176353</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ttler T., G&#xf6;rlich D. Ran-dependent nuclear export mediators: A structural perspective. EMBO J. 2011;30:3457&#x2013;3474. doi: 10.1038/emboj.2011.287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.287</ArticleId><ArticleId IdType="pmc">PMC3181476</ArticleId><ArticleId IdType="pubmed">21878989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C.J., Haeusler A.R., Grima J.C., Machamer J.B., Steinwald P., Daley E.L., Miller S.J., Cunningham K.M., Vidensky S., et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizawa H., Yamashita T., Kato H., Kimura T., Kwak S. Impaired nucleoporins are present in sporadic amyotrophic lateral sclerosis motor neurons that exhibit mislocalization of the 43-kDa TAR DNA-binding protein. J. Clin. Neurol. 2019;15:62&#x2013;67. doi: 10.3988/jcn.2019.15.1.62.</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2019.15.1.62</ArticleId><ArticleId IdType="pmc">PMC6325357</ArticleId><ArticleId IdType="pubmed">30618218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita Y., Ito H., Hirano A., Fujita K., Wate R., Nakamura M., Kaneko S., Nakano S., Kusaka H. Nuclear contour irregularity and abnormal transporter protein distribution in anterior horn cells in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2009;68:1184&#x2013;1192. doi: 10.1097/NEN.0b013e3181bc3bec.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181bc3bec</ArticleId><ArticleId IdType="pubmed">19816199</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Yamashita T., Nakano Y., Morihara R., Li X., Feng T., Huang Y., Fukui Y., Hishikawa N., Abe K., et al. Aberrant distributions of nuclear pore complex proteins in ALS mice and ALS patients. Neuroscience. 2017;350:158&#x2013;168. doi: 10.1016/j.neuroscience.2017.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.03.024</ArticleId><ArticleId IdType="pubmed">28344074</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S., Stauffer J.E., Jiang J., Garcia S.D., Taylor A.E., Schulte D., Ohkubo T., Schloffman C.L., Maldonado M., Baughn M., et al. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:459&#x2013;474. doi: 10.1007/s00401-017-1793-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1793-8</ArticleId><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon D.A., Stepto A., Au W.H., Adachi Y., Diaper D.C., Hall R., Rekhi A., Boudi A., Tziortzouda P., Lee Y.-B., et al. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-&#x3b1; mediates C9orf72-related neurodegeneration. Brain. 2018;141:2908&#x2013;2924. doi: 10.1093/brain/awy241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy241</ArticleId><ArticleId IdType="pmc">PMC6158706</ArticleId><ArticleId IdType="pubmed">30239641</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Zaepfel B.L., Hayes L., Fitchman B., Salzberg Y., Luo E.-C., Bowen K., Trost H., Aigner S., Rigo F., et al. G4C2 Repeat RNA initiates a POM121-mediated reduction in specific nucleoporins in C9orf72 ALS/FTD. Neuron. 2020;107:1124&#x2013;1140. doi: 10.1016/j.neuron.2020.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.06.027</ArticleId><ArticleId IdType="pmc">PMC8077944</ArticleId><ArticleId IdType="pubmed">32673563</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.-C., Zhang Y., Umoh M.E., Vaughan S.W., Lorenzini I., Liu F., Sayegh M., Donlin-Asp P.G., Chen Y.H., Rossoll W. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Baskerville V., Zaepfel B.L., Dickson D.W., Rigo F., Bennett F., Lusk C.P., Rothstein J.D. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. Sci. Transl. Med. 2021;13:eabe1923. doi: 10.1126/scitranslmed.abe1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe1923</ArticleId><ArticleId IdType="pubmed">34321318</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A., Mertens J., Boeynaems S., Bogaert E., Chai N., Yamada S.B., Paul J.W., 3rd, Sun S., Herdy J.R., Bieri G., et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 2015;18:1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Woerner A.C., Frottin F., Hornburg D., Feng L.R., Meissner F., Patra M., Tatzelt J., Mann M., Winklhofer K.F., Hartl F.U., et al. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science. 2016;351:173&#x2013;176. doi: 10.1126/science.aad2033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad2033</ArticleId><ArticleId IdType="pubmed">26634439</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., Jara J.H., Kocak N., Rylaarsdam L.E., Kim K.D., Bigio E.H., Hande &#xd6;zdinler P. Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta Neuropathol. 2019;137:47&#x2013;69. doi: 10.1007/s00401-018-1934-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1934-8</ArticleId><ArticleId IdType="pmc">PMC6339587</ArticleId><ArticleId IdType="pubmed">30450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J., Cook C., Gendron T.F., Jansen-West K., Del Rosso G., Daughrity L.M., Castanedes-Casey M., Kurti A., Stankowski J.N., Disney M.D., et al. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol. Neurodegener. 2019;14:9. doi: 10.1186/s13024-019-0310-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0310-z</ArticleId><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabut G., Doye V., Ellenberg J. Mapping the dynamic organization of the nuclear pore complex inside single living cells. Nat. Cell Biol. 2004;6:1114&#x2013;1121. doi: 10.1038/ncb1184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1184</ArticleId><ArticleId IdType="pubmed">15502822</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Rothstein J.D. Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD. Acta Neuropathol. Commun. 2021;9:45. doi: 10.1186/s40478-021-01150-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01150-5</ArticleId><ArticleId IdType="pmc">PMC7977268</ArticleId><ArticleId IdType="pubmed">33741069</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai S.C., Nana A.L., Yokoyama J.S., Seeley W.W. C9orf72-FTD/ALS pathogenesis: Evidence from human neuropathological studies. Acta Neuropathol. 2019;137:1&#x2013;26. doi: 10.1007/s00401-018-1921-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1921-0</ArticleId><ArticleId IdType="pmc">PMC6546170</ArticleId><ArticleId IdType="pubmed">30368547</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.C., Kumar M.S., Ramesh N., Anderson E.N., Nguyen A.T., Kim B., Cheung S., McDonough J.A., Skarnes W.C., Lopez-Gonzalez R., et al. Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. Nat. Neurosci. 2021;24:1077&#x2013;1088. doi: 10.1038/s41593-021-00859-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00859-9</ArticleId><ArticleId IdType="pubmed">34059832</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi B., Hartmann H., May S., M&#xf6;hl C., Ederle H., Michaelsen M., Schludi M.H., Dormann D., Edbauer D. Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD. Hum. Mol. Genet. 2017;26:790&#x2013;800. doi: 10.1093/hmg/ddw432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw432</ArticleId><ArticleId IdType="pmc">PMC5409121</ArticleId><ArticleId IdType="pubmed">28040728</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyaert J., Scheveneels W., Vanneste J., Van Damme P., Robberecht W., Callaerts P., Bogaert E., Van Den Bosch L. FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins. Hum. Mol. Genet. 2018;27:4103&#x2013;4116. doi: 10.1093/hmg/ddy303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy303</ArticleId><ArticleId IdType="pmc">PMC6240733</ArticleId><ArticleId IdType="pubmed">30379317</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold H.C., Jackson K.L., Arora A., Weskamp K., Tank E.M.H., Li X., Miguez R., Dayton R.D., Tamir S., Klein R.L., et al. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci. Rep. 2018;8:4606. doi: 10.1038/s41598-018-22858-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22858-w</ArticleId><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Kasper L.H., Mantcheva R.T., Mantchev G.T., Springett M.J., van Deursen J.M. Disruption of the FG nucleoporin NUP98 causes selective changes in nuclear pore complex stoichiometry and function. Proc. Natl. Acad. Sci. USA. 2001;98:3191&#x2013;3196. doi: 10.1073/pnas.051631598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.051631598</ArticleId><ArticleId IdType="pmc">PMC30629</ArticleId><ArticleId IdType="pubmed">11248054</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther T.C., Alves A., Pickersgill H., Lo&#xef;odice I., Hetzer M., Galy V., H&#xfc;lsmann B.B., K&#xf6;cher T., Wilm M., Allen T., et al. The conserved Nup107-160 complex is critical for nuclear pore complex assembly. Cell. 2003;113:195&#x2013;206. doi: 10.1016/S0092-8674(03)00235-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(03)00235-6</ArticleId><ArticleId IdType="pubmed">12705868</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angelo M.A., Raices M., Panowski S.H., Hetzer M.W. Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell. 2009;136:284&#x2013;295. doi: 10.1016/j.cell.2008.11.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.11.037</ArticleId><ArticleId IdType="pmc">PMC2805151</ArticleId><ArticleId IdType="pubmed">19167330</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmelink M.F.W., Steen A., Veenhoff L.M. Measuring and interpreting nuclear transport in neurodegenerative disease&#x2014;The example of C9orf72 ALS. Int. J. Mol. Sci. 2021;22:9217. doi: 10.3390/ijms22179217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179217</ArticleId><ArticleId IdType="pmc">PMC8431710</ArticleId><ArticleId IdType="pubmed">34502125</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Daigle J.G., Cunningham K.M., Coyne A.N., Ruan K., Grima J.C., Bowen K.E., Wadhwa H., Yang P., Rigo F., et al. Stress granule assembly disrupts nucleocytoplasmic transport. Cell. 2018;173:958&#x2013;971. doi: 10.1016/j.cell.2018.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.025</ArticleId><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J., Vercruysse T., Boeynaems S., Sicart A., Van Damme P., Daelemans D., Van Den Bosch L. C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocytoplasmic transport. Sci. Rep. 2019;9:15728. doi: 10.1038/s41598-019-52035-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-52035-6</ArticleId><ArticleId IdType="pmc">PMC6823349</ArticleId><ArticleId IdType="pubmed">31673013</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J., Vercruysse T., Van Damme P., Van Den Bosch L., Daelemans D. Quantitative nucleocytoplasmic transport assays in cellular models of neurodegeneration. Bio-Protocol. 2020;10:e3659. doi: 10.21769/BioProtoc.3659.</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.3659</ArticleId><ArticleId IdType="pmc">PMC7842572</ArticleId><ArticleId IdType="pubmed">33659329</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahboubi H., Seganathy E., Kong D., Stochaj U. Identification of novel stress granule components that are involved in nuclear transport. PLoS ONE. 2013;8:e68356. doi: 10.1371/journal.pone.0068356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0068356</ArticleId><ArticleId IdType="pmc">PMC3694919</ArticleId><ArticleId IdType="pubmed">23826389</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimura K., Suzuki T., Yasuda Y., Murata M., Katahira J., Yoneda Y. Identification of importin &#x3b1;1 as a novel constituent of RNA stress granules. Biochim. Biophys. Acta (BBA) Mol. Cell Res. 2010;1803:865&#x2013;871. doi: 10.1016/j.bbamcr.2010.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2010.03.020</ArticleId><ArticleId IdType="pubmed">20362631</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W.-L., Tarn W.-Y. A role for transportin in deposition of TTP to cytoplasmic RNA granules and mRNA decay. Nucleic Acids Res. 2009;37:6600&#x2013;6612. doi: 10.1093/nar/gkp717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp717</ArticleId><ArticleId IdType="pmc">PMC2770677</ArticleId><ArticleId IdType="pubmed">19729507</ArticleId></ArticleIdList></Reference><Reference><Citation>Katahira J., Miki T., Takano K., Maruhashi M., Uchikawa M., Tachibana T., Yoneda Y. Nuclear RNA export factor 7 is localized in processing bodies and neuronal RNA granules through interactions with shuttling hnRNPs. Nucleic Acids Res. 2008;36:616&#x2013;628. doi: 10.1093/nar/gkm556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm556</ArticleId><ArticleId IdType="pmc">PMC2241847</ArticleId><ArticleId IdType="pubmed">18063567</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J., Vercruysse T., Boeynaems S., Van Damme P., Daelemans D., Van Den Bosch L. Stress induces nucleocytoplasmic transport deficits independent of stress granules. 2021 submitted.</Citation></Reference><Reference><Citation>Biogen  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100.  [(accessed on 18 December 2020)];2019  Available online:  https://www.clinicaltrials.gov/ct2/show/NCT03945279?term=biib100&amp;rank=1.</Citation></Reference><Reference><Citation>Guo L., Fare C.M., Shorter J. Therapeutic dissolution of aberrant phases by nuclear-import receptors. Trends Cell Biol. 2019;29:308&#x2013;322. doi: 10.1016/j.tcb.2018.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2018.12.004</ArticleId><ArticleId IdType="pmc">PMC6750949</ArticleId><ArticleId IdType="pubmed">30660504</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ttinger S., Laurell E., Kutay U. Orchestrating nuclear envelope disassembly and reassembly during mitosis. Nat. Rev. Mol. Cell Biol. 2009;10:178&#x2013;191. doi: 10.1038/nrm2641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2641</ArticleId><ArticleId IdType="pubmed">19234477</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyama B.H., Savas J.N., Park S.K., Harris M.S., Ingolia N.T., Yates J.R., III, Hetzer M.W. Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell. 2013;154:971&#x2013;982. doi: 10.1016/j.cell.2013.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.07.037</ArticleId><ArticleId IdType="pmc">PMC3788602</ArticleId><ArticleId IdType="pubmed">23993091</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens J., Paquola A.C.M., Ku M., Hatch E., B&#xf6;hnke L., Ladjevardi S., McGrath S., Campbell B., Lee H., Herdy J.R., et al. Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell. 2015;17:705&#x2013;718. doi: 10.1016/j.stem.2015.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2015.09.001</ArticleId><ArticleId IdType="pmc">PMC5929130</ArticleId><ArticleId IdType="pubmed">26456686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujol G., S&#xf6;derqvist H., Radu A. Age-associated reduction of nuclear protein import in human fibroblasts. Biochem. Biophys. Res. Commun. 2002;294:354&#x2013;358. doi: 10.1016/S0006-291X(02)00492-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-291X(02)00492-8</ArticleId><ArticleId IdType="pubmed">12051719</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>